Dubravka Cvejic

Summary

Affiliation: Institute for the Application of Nuclear Energy
Country: Serbia and Montenegro

Publications

  1. ncbi Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue
    D Cvejic
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Yugoslavia
    Anticancer Res 18:2637-41. 1998
  2. ncbi Galectin-3 expression in papillary microcarcinoma of the thyroid
    D Cvejic
    Institute for the Application of Nuclear Energy, INEP, University of Belgrade, Zumun, Belgrade, Serbia
    Histopathology 47:209-14. 2005
  3. ncbi Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size
    Dubravka S Cvejic
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, 11080 Zemun Belgrade, Banatska 31b, Serbia and Montenegro
    Head Neck 27:1049-55. 2005
  4. ncbi Galectin-3 and proliferating cell nuclear antigen (PCNA) expression in papillary thyroid carcinoma
    D Cvejic
    Institute for the Application of Nuclear Energy INEP, Zemun, Belgrade, Serbia and Montenegro
    Exp Oncol 27:210-4. 2005
  5. doi Apoptosis and proliferation related molecules (Bcl-2, Bax, p53, PCNA) in papillary microcarcinoma versus papillary carcinoma of the thyroid
    Dubravka Cvejic
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Serbia
    Pathology 40:475-80. 2008
  6. ncbi Changes in the balance between proliferation and apoptosis during the progression of malignancy in thyroid tumours
    D Cvejic
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Zemun Belgrade, Serbia
    Eur J Histochem 53:65-71. 2009
  7. doi Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation
    Svetlana Savin
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Zemun Belgrade, Serbia
    Hum Pathol 39:1656-63. 2008
  8. ncbi Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma
    Ilona Marečko
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Zemun Belgrade, Serbia
    Cancer Biomark 11:49-58. 2011
  9. doi Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors
    Tijana Isic
    Institute for the Application of Nuclear Energy, INEP, University of Belgrade, Banatska 31b, 11080 Zemun, Belgrade, Serbia
    J Cancer Res Clin Oncol 136:1805-12. 2010
  10. doi Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status
    Svetlana Paskas
    Institute for the Application of Nuclear Energy INEP, Department for Endocrinology and Immunoradiology, Belgrade, Serbia
    Otolaryngol Head Neck Surg 150:201-9. 2014

Collaborators

Detail Information

Publications17

  1. ncbi Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue
    D Cvejic
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Yugoslavia
    Anticancer Res 18:2637-41. 1998
    ..The purpose of this study was to analyze galectin-3 expression in a series of human thyroid neoplastic lesions...
  2. ncbi Galectin-3 expression in papillary microcarcinoma of the thyroid
    D Cvejic
    Institute for the Application of Nuclear Energy, INEP, University of Belgrade, Zumun, Belgrade, Serbia
    Histopathology 47:209-14. 2005
    ..As reported in several studies, galectin-3 is highly expressed in papillary thyroid carcinoma, but its expression has not been investigated in papillary microcarcinoma, which is a variant of papillary thyroid carcinoma...
  3. ncbi Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size
    Dubravka S Cvejic
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, 11080 Zemun Belgrade, Banatska 31b, Serbia and Montenegro
    Head Neck 27:1049-55. 2005
    ..Galectin-3 has been recently recognized as a promising presurgical marker of thyroid malignancy...
  4. ncbi Galectin-3 and proliferating cell nuclear antigen (PCNA) expression in papillary thyroid carcinoma
    D Cvejic
    Institute for the Application of Nuclear Energy INEP, Zemun, Belgrade, Serbia and Montenegro
    Exp Oncol 27:210-4. 2005
    ..However, its exact role in thyroid tumor biology is still unknown...
  5. doi Apoptosis and proliferation related molecules (Bcl-2, Bax, p53, PCNA) in papillary microcarcinoma versus papillary carcinoma of the thyroid
    Dubravka Cvejic
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Serbia
    Pathology 40:475-80. 2008
    ..To gain a better insight into the differences in biological behaviour between papillary microcarcinoma (PMC) and clinically evident papillary thyroid carcinoma (PTC)...
  6. ncbi Changes in the balance between proliferation and apoptosis during the progression of malignancy in thyroid tumours
    D Cvejic
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Zemun Belgrade, Serbia
    Eur J Histochem 53:65-71. 2009
    ....
  7. doi Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation
    Svetlana Savin
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Zemun Belgrade, Serbia
    Hum Pathol 39:1656-63. 2008
    ....
  8. ncbi Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma
    Ilona Marečko
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Zemun Belgrade, Serbia
    Cancer Biomark 11:49-58. 2011
    ....
  9. doi Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors
    Tijana Isic
    Institute for the Application of Nuclear Energy, INEP, University of Belgrade, Banatska 31b, 11080 Zemun, Belgrade, Serbia
    J Cancer Res Clin Oncol 136:1805-12. 2010
    ....
  10. doi Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status
    Svetlana Paskas
    Institute for the Application of Nuclear Energy INEP, Department for Endocrinology and Immunoradiology, Belgrade, Serbia
    Otolaryngol Head Neck Surg 150:201-9. 2014
    ..We aimed to investigate the role of caveolin-1 in papillary thyroid carcinoma pathogenesis...
  11. doi Cytokeratin19 expression discriminates papillary thyroid carcinoma from other thyroid lesions and predicts its aggressive behavior
    Tijana Isic Dencic
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31b, 11080 Zemun, Belgrade, Serbia
    Med Oncol 30:362. 2013
    ..High expression of this protein predicts the aggressive behavior of PTC and can help in the identification of a particular subgroup of PTC patients with a potentially worse prognosis...
  12. doi Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors
    Ivan Paunovic
    Center for Endocrine Surgery, Institute of Endocrinology, Diabetes and Diseases of Metabolism, University of Belgrade, Serbia
    APMIS 120:368-79. 2012
    ..1%. HBME-1 is the most accurate ancillary stain in discriminating well-differentiated thyroid carcinomas from benign tumors, although the addition of TPO did improve accuracy and served as a useful confirmatory marker...
  13. ncbi Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors
    Svetlana Savin
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, Zemun, Belgrade
    Endocr Pathol 17:53-60. 2006
    ....
  14. pmc Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration
    Ilona Marečko
    Svetlana Savin, Institute for the Application of Nuclear Energy INEP, University of Belgrade, Banatska 31b, 11080 Zemun Belgrade, Serbia
    Croat Med J 55:128-37. 2014
    ....
  15. ncbi Matrix metalloproteinase-9 and the Cu/Zn ratio as ancillary diagnostic tools in distinguishing between the classical and follicular variants of papillary thyroid carcinoma
    Vesna V Dragutinović
    Institute of Medical Chemistry, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
    Biol Trace Elem Res 149:29-33. 2012
    ..Thus, determining MMP-9 activities and the Cu/Zn ratios could improve the accuracy of the standard histopathological diagnosis of these two types of PTC...
  16. doi Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma
    Sonja Selemetjev
    Institute for the Application of Nuclear Energy INEP, University of Belgrade, 11080 Zemun, Belgrade, Serbia
    Pathol Res Pract 210:30-4. 2014
    ..Evaluation of its expression in fine needle aspiration samples could be a useful tool for the identification of those PTC patients who require more extensive surgery, careful follow-up and therapeutic strategy. ..
  17. pmc Caveolin-1 expression in thyroid neoplasia spectrum: comparison of two commercial antibodies
    Jelena Jankovic
    Institute for the Application of Nuclear Energy INEP, Department for Endocrinology and Immunoradiology, University of Belgrade, Serbia
    Dis Markers 33:321-31. 2012
    ..In addition, increased expression of caveolin-1 may be considered as an indicator of papillary carcinoma progression...